Log in

Lucid Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/28/2020 12:00 AM ET)
Today's Range
Now: $0.65
50-Day Range
MA: $1.06
52-Week Range
Now: $0.65
Volume55,101 shs
Average Volume185,898 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Current SymbolOTCMKTS:LCDX



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable
0.00 (0.00 %)
(As of 09/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LCDX News and Ratings via Email

Sign-up to receive the latest news and ratings for LCDX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Lucid (OTCMKTS:LCDX) Frequently Asked Questions

How has Lucid's stock been impacted by COVID-19?

Lucid's stock was trading at $0.73 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, LCDX shares have decreased by 11.3% and is now trading at $0.6475.
View which stocks have been most impacted by COVID-19

Are investors shorting Lucid?

Lucid saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 20,300 shares, a decrease of 66.9% from the August 31st total of 61,400 shares. Based on an average daily trading volume, of 343,500 shares, the short-interest ratio is currently 0.1 days.
View Lucid's Short Interest

Who are some of Lucid's key competitors?

What other stocks do shareholders of Lucid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lucid investors own include Etsy (ETSY), J C Penney (JCP), NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Youdao (DAO), Costco Wholesale (COST), IBM (IBM), Netflix (NFLX) and QUALCOMM (QCOM).

Who are Lucid's key executives?

Lucid's management team includes the following people:
  • Mr. William J. Shea, Exec. Chairman (Age 71)
  • Mr. L. Michael Hone, CEO & Director (Age 69)
  • Mr. William J. Fox, CTO & VP of Technology Operations (Age 53)
  • Ms. Karen Howe, Chief Financial Officer
  • Mr. Robert T. Kelley, VP of Sales and Marketing

What is Lucid's stock symbol?

Lucid trades on the OTCMKTS under the ticker symbol "LCDX."

How do I buy shares of Lucid?

Shares of LCDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Lucid's stock price today?

One share of LCDX stock can currently be purchased for approximately $0.65.

What is Lucid's official website?

The official website for Lucid is www.caliberid.com.

How can I contact Lucid?

Lucid's mailing address is 100 Burtt Rd Ste 203, ANDOVER, MA 01810-5920, United States. The company can be reached via phone at +1-585-2399800.

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.